The results of the present study demonstrated that triciribine, an inhibitor of Akt, partially weakened the effects of urocortin on DCM and the Akt/GSK-β pathways involved in mediating the effects of urocortin on DCM. Here, AKT1 is linked to familial dilated cardiomyopathy.